Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines.
Original Article: Lisinopril and Carvedilol Reduce Cardiotoxicity in HER2+ Breast Cancer